VRAR stock news
This page provides real-time market news, earnings updates, and company announcements related to The Glimpse Group, Inc. (VRAR).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-23 08:13 EST
On February 20, Resolute Holdings Management Inc (stock code: RHLD) officially signed a new credit agreement with U.S. banking giant JPMorgan.
老虎证券2026-02-23 12:57:43
Dominion Resources announced that the company has decided to maintain its long-term annual operating earnings per share (EPS) growth guidance range at 5% to 7%, and specifically emphasized that during the period from 2028 to 2030, the growth rate is expected to be toward the upper end of this range.
老虎证券2026-02-23 12:57:50
Gibraltar Industries recently disclosed that the sale of its renewable energy racking and foundation business has entered a substantive advancement stage.
老虎证券2026-02-23 12:58:56
On February 22, Ortenzio Robert formally submitted an optimized non-binding acquisition proposal to the special committee of the board of directors of Select Medical Holdings.
老虎证券2026-02-23 12:58:58
Recursion to Participate in Upcoming Investor Conferences
Finviz2026-02-23 12:57:48
Ortenzio Robert has officially made a tender offer, planning to acquire all outstanding shares of Select Medical (NYSE: SEM) that he does not already own at a cash price of $16.00 per share.
老虎证券2026-02-23 12:59:01
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), Resolute Holdings Management Inc (RHLD) has completed a significant adjustment to its financing structure.
老虎证券2026-02-23 12:59:06
UroGen Pharma to Report Fourth Quarter and Full-Year 2025 Financial Results on Monday, March 2, 2026
Finviz2026-02-23 13:03:45
Dare Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer
Finviz2026-02-23 13:03:44
Mount Logan Capital Inc. Announces $10 Million Share Repurchase Program
Finviz2026-02-23 13:03:46
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-23 13:03:47
The Oncology Institute Appoints Kim Tzoumakas to Board of Directors
Finviz2026-02-23 13:03:45
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
Finviz2026-02-23 13:03:49
Getty Images and Shutterstock Receive Unconditional Antitrust Clearance from U.S. Department of Justice for Proposed Merger
Finviz2026-02-23 13:03:49
Leading Heart Transplant Centers Convene in Houston for Picard Medical/ SynCardia's Total Artificial Heart Surgical Training
Finviz2026-02-23 13:03:49
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Finviz2026-02-23 13:03:47
Geron Plans to Present at Upcoming Investor Conferences
Finviz2026-02-23 13:03:49
BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day
Finviz2026-02-23 13:03:50
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Finviz2026-02-23 13:03:47
Join Biovie's Exclusive Live Investor Webinar and Q&A Session on March 4
Finviz2026-02-23 13:03:50
Celldex Announces Multiple Upcoming Presentations at AAAAI 2026 Supporting Barzolvolimab's First-in-Class and Best-in-Disease Profile
Finviz2026-02-23 13:04:05
This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease
Finviz2026-02-23 13:03:48
Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Finviz2026-02-23 13:03:48
LENZ Therapeutics to Present at Upcoming Investor Conferences
Finviz2026-02-23 13:03:51
Recursion to Participate in Upcoming Investor Conferences
Finviz2026-02-23 12:57:48
Ortenzio Robert has officially made a tender offer, planning to acquire all outstanding shares of Select Medical (NYSE: SEM) that he does not already own at a cash price of $16.00 per share.
老虎证券2026-02-23 12:59:01
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), Resolute Holdings Management Inc (RHLD) has completed a significant adjustment to its financing structure.
老虎证券2026-02-23 12:59:06
UroGen Pharma to Report Fourth Quarter and Full-Year 2025 Financial Results on Monday, March 2, 2026
Finviz2026-02-23 13:03:45
Dare Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer
Finviz2026-02-23 13:03:44
Mount Logan Capital Inc. Announces $10 Million Share Repurchase Program
Finviz2026-02-23 13:03:46
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-23 13:03:47
The Oncology Institute Appoints Kim Tzoumakas to Board of Directors
Finviz2026-02-23 13:03:45
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
Finviz2026-02-23 13:03:49
Getty Images and Shutterstock Receive Unconditional Antitrust Clearance from U.S. Department of Justice for Proposed Merger
Finviz2026-02-23 13:03:49
Leading Heart Transplant Centers Convene in Houston for Picard Medical/ SynCardia's Total Artificial Heart Surgical Training
Finviz2026-02-23 13:03:49
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Finviz2026-02-23 13:03:47
Geron Plans to Present at Upcoming Investor Conferences
Finviz2026-02-23 13:03:49
BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day
Finviz2026-02-23 13:03:50
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Finviz2026-02-23 13:03:47
Join Biovie's Exclusive Live Investor Webinar and Q&A Session on March 4
Finviz2026-02-23 13:03:50
Celldex Announces Multiple Upcoming Presentations at AAAAI 2026 Supporting Barzolvolimab's First-in-Class and Best-in-Disease Profile
Finviz2026-02-23 13:04:05
This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease
Finviz2026-02-23 13:03:48
Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Finviz2026-02-23 13:03:48
LENZ Therapeutics to Present at Upcoming Investor Conferences
Finviz2026-02-23 13:03:51
VRAR stock chart
VRAR stock detailsVRAR stock price change
On the last trading day, VRAR stock closed at 0.77 USD, with a price change of 4.32% for the day.
Trade stock futuresAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more